CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 275 filers reported holding CANTEL MEDICAL CORP in Q1 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $541,000 | +25.5% | 6,776 | +24.0% | 0.00% | 0.0% |
| Q4 2020 | $431,000 | +95.9% | 5,463 | +9.3% | 0.00% | 0.0% |
| Q3 2020 | $220,000 | -68.0% | 5,000 | -67.8% | 0.00% | -72.7% |
| Q2 2020 | $687,000 | -13.6% | 15,532 | -29.9% | 0.01% | -45.0% |
| Q1 2020 | $795,000 | -44.5% | 22,144 | +15.6% | 0.02% | +53.8% |
| Q3 2019 | $1,432,000 | +71.7% | 19,150 | +85.2% | 0.01% | +62.5% |
| Q2 2019 | $834,000 | +22.5% | 10,341 | +1.5% | 0.01% | +14.3% |
| Q1 2019 | $681,000 | -70.9% | 10,186 | -67.6% | 0.01% | -74.1% |
| Q4 2018 | $2,344,000 | -24.0% | 31,480 | -6.0% | 0.03% | -27.0% |
| Q3 2018 | $3,084,000 | -63.2% | 33,502 | -60.7% | 0.04% | -66.7% |
| Q2 2018 | $8,387,000 | +1363.7% | 85,269 | +1558.3% | 0.11% | +1133.3% |
| Q1 2018 | $573,000 | +69.0% | 5,142 | +55.9% | 0.01% | +50.0% |
| Q4 2017 | $339,000 | -70.5% | 3,298 | -73.0% | 0.01% | -72.7% |
| Q3 2017 | $1,149,000 | +259.1% | 12,199 | +162.1% | 0.02% | +10.0% |
| Q2 2016 | $320,000 | – | 4,654 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DIKER MANAGEMENT LLC | 1,383,325 | $136,064,000 | 48.67% |
| Brown Capital Management | 3,345,000 | $329,014,000 | 3.38% |
| Kimelman & Baird, LLC | 206,142 | $20,276,000 | 2.66% |
| Conestoga Capital Advisors, LLC | 690,673 | $67,935,000 | 2.19% |
| WASATCH ADVISORS LP | 1,772,992 | $174,391,000 | 2.10% |
| Ranger Investment Management | 280,989 | $27,638,000 | 1.93% |
| Freedom Day Solutions, LLC | 21,938 | $2,158,000 | 1.76% |
| CAPITAL INSIGHT PARTNERS, LLC | 17,853 | $1,756,000 | 1.44% |
| Geller Advisors LLC | 22,700 | $2,233,000 | 0.97% |
| Sapphire Star Partners LP | 8,607 | $846,000 | 0.87% |